Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Targeted therapy for advanced colorectal cancer--more is not always better.

Mayer RJ.

N Engl J Med. 2009 Feb 5;360(6):623-5. doi: 10.1056/NEJMe0809343. No abstract available.

PMID:
19196680
2.

Chemotherapy and immunotherapy in metastatic colorectal cancer.

Copur MS, Norvell M, Obermiller A.

N Engl J Med. 2009 May 14;360(20):2135; author reply 2135-6. No abstract available.

PMID:
19445033
3.

Current questions in the treatment of advanced colorectal cancer: the CAIRO studies of the Dutch Colorectal Cancer Group.

Simkens L, Tol J, Koopman M, Mol L, Antonini N, van Krieken H, Punt C.

Clin Colorectal Cancer. 2008 Mar;7(2):105-9. doi: 10.3816/CCC.2008.n.014. Review.

PMID:
18501069
4.

First-line treatment of advanced colorectal cancer.

Hewish M, Cunningham D.

Lancet. 2011 Jun 18;377(9783):2060-2. doi: 10.1016/S0140-6736(11)60788-5. Epub 2011 Jun 5. No abstract available. Erratum in: Lancet. 2011 Jun 18;377(9783):2084.

PMID:
21641637
5.

Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.

Booth C.

J Clin Oncol. 2008 Oct 1;26(28):4693-4; author reply 4694-5. doi: 10.1200/JCO.2008.18.8060. No abstract available.

PMID:
18824719
6.

Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer.

Morse MA.

IDrugs. 2005 Dec;8(12):974-7. No abstract available.

PMID:
16320126
7.

Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008.

Gibson TB, Grothey E, Chu E.

Clin Colorectal Cancer. 2008 Jul;7(4):233-9. No abstract available.

PMID:
18650191
8.

Comment on 'capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer'.

Molina-Garrido MJ, Guillén-Ponce C.

Br J Cancer. 2011 Jan 4;104(1):224-5; author reply 226. doi: 10.1038/sj.bjc.6606037. Epub 2010 Dec 14. No abstract available.

9.

Current role of bevacizumab in colorectal cancer.

Saltz L.

Clin Adv Hematol Oncol. 2009 Jun;7(6):375-6. No abstract available.

PMID:
19606071
10.

Combined-modality therapy for rectal cancer: future prospects.

Czito BG, Willett CG, Bendell JC.

Clin Colorectal Cancer. 2007 Sep;6(9):625-33. Review.

PMID:
17945034
11.

Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.

Dohn LH, Jensen BV, Larsen FO.

Acta Oncol. 2010 Apr;49(3):395-6. doi: 10.3109/02841860903428184. No abstract available.

PMID:
20001495
12.

Current issues in the targeted therapy of advanced colorectal cancer.

Knijn N, Tol J, Punt CJ.

Discov Med. 2010 Apr;9(47):328-36. Review.

13.
14.

First- and second-line therapy of metastatic colorectal cancer.

Terstriep S, Grothey A.

Expert Rev Anticancer Ther. 2006 Jun;6(6):921-30. Review.

PMID:
16761936
15.

[Application of monoclonal antibody in combination with irinotecan in the treatment of colorectal cancer].

Li J.

Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):796-7. Review. Chinese. No abstract available.

PMID:
17366800
16.

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

Price TJ, Hardingham JE, Lee CK, Weickhardt A, Townsend AR, Wrin JW, Chua A, Shivasami A, Cummins MM, Murone C, Tebbutt NC.

J Clin Oncol. 2011 Jul 1;29(19):2675-82. doi: 10.1200/JCO.2010.34.5520. Epub 2011 Jun 6.

PMID:
21646616
17.

Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.

Schaller G, Fuchs I, Gonsch T, Weber J, Kleine-Tebbe A, Klare P, Hindenburg HJ, Lakner V, Hinke A, Bangemann N.

J Clin Oncol. 2007 Aug 1;25(22):3246-50. Epub 2007 Jun 18.

PMID:
17577021
18.

Molecular therapy of pancreatic cancer.

Plentz RR, Manns MP, Greten TF.

Minerva Endocrinol. 2010 Mar;35(1):27-33. Review.

PMID:
20386525
20.

Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?

Yanagisawa Y, Midgley RS.

Nat Rev Clin Oncol. 2010 Oct;7(10):556-7. doi: 10.1038/nrclinonc.2010.140. No abstract available.

PMID:
20877418

Supplemental Content

Support Center